Gadobenate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
OBJECTIVE The purpose of this study was to retrospectively evaluate the diagnostic performance of dynamic gadobenate dimeglumine… (More)
  • table 1
  • table 3
  • figure 1—55
  • table 4
  • figure 2—47
Is this relevant?
2008
2008
OBJECTIVE The objective of our study was to intraindividually compare 0.1 mmol/kg doses of gadobenate dimeglumine and… (More)
Is this relevant?
2007
2007
BACKGROUND Gadolinium chelates are relatively safe contrast media used in MRI. Immediate severe adverse effects are exceptionally… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To prospectively determine the accuracy of differentiating benign focal nodular hyperplasia (FNH) from hepatic adenoma… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
PURPOSE To prospectively and intraindividually compare equivalent (0.1 mmol per kilogram of body weight) doses of gadobenate… (More)
Is this relevant?
2004
2004
PURPOSE To evaluate the safety of and compare the enhancement characteristics of gadobenate dimeglumine (MultiHance; Bracco… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
RATIONALE AND OBJECTIVES Gadobenate dimeglumine (Gd-BOPTA) has a two-fold higher T1 relaxivity compared with gadopentetate… (More)
Is this relevant?
1999
1999
RATIONALE AND OBJECTIVES To determine the safety and pharmacokinetics of gadobenate dimeglumine in a group of subjects with… (More)
Is this relevant?
1999
1999
OBJECTIVE Evaluation of the pharmacokinetic behavior of gadobenate dimeglumine, a new multipurpose parenteral contrast agent for… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
RATIONALE AND OBJECTIVES The authors assess the effect of weak protein binding on the efficacy of gadolinium chelates as contrast… (More)
Is this relevant?